斯里兰卡急性冠脉综合征患者管理、特征与结局
ACSSLAP是斯里兰卡首个全国性临床审计项目,前瞻性评估87家公立医院2116例ACS患者的急性期与出院管理。结果显示阿司匹林、氯吡格雷和他汀使用率超过90%,但STEMI再灌注以溶栓为主(63.2%),仅3.8%接受直接PCI,及时溶栓和PCI延迟达标率低,出院β受体阻滞剂和ACEI/ARB使用不足。
要点
- ACS患者中不稳定心绞痛占38.4%,NSTEMI占32.8%,STEMI占28.7%。
- STEMI再灌注率66.9%,其中溶栓63.2%,直接PCI仅3.8%。
- 仅42.3%溶栓在30分钟内完成,62.5% PCI在90分钟内完成。
核心结论
- 阿司匹林、氯吡格雷和他汀在急性期和出院时使用达到审计标准。
- STEMI再灌注以溶栓为主,直接PCI、计划冠脉干预和及时溶栓需改善。
研究设计与样本
- ACSSLAP为前瞻性全国临床审计项目,纳入87/98家(88.7%)公立医院连续30例ACS患者,共2177例,其中2116例确诊ACS。
主要发现
- 平均年龄61.4±11.8岁,男性占58.7%(n=1242)。
- 不稳定心绞痛813例(38.4%),NSTEMI 695例(32.8%),STEMI 608例(28.7%)。
- STEMI再灌注407例(66.9%),溶栓384例(63.2%),直接PCI 23例(3.8%)。
- 溶栓<30分钟占42.3%,PCI<90分钟占62.5%。
- 出院β受体阻滞剂50.7%,ACEI/ARB 69.2%,计划冠脉干预17.6%。
关键数值与推荐
- 采用本地和国际推荐作为审计标准。
- 阿司匹林、氯吡格雷和他汀在急性期和出院时使用率均超过90%。
临床怎么用
- 应优先改善STEMI直接PCI可及性和及时溶栓达标率。
- 需提高出院β受体阻滞剂和ACEI/ARB的处方率及计划冠脉干预比例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ischaemic heart disease is the leading cause of in-hospital mortality in Sri Lanka. Acute Coronary Syndrome Sri Lanka Audit Project (ACSSLAP) is the first national clinical-audit project that evaluated patient characteristics, clinical outcomes and care provided by state-sector hospitals. METHODS: ACSSLAP prospectively evaluated acute care, in-hospital care and discharge plans provided by all state-sector hospitals managing patients with ACS. Data were collected from 30 consecutive patients from each hospital during 2-4 weeks window. Local and international recommendations were used as audit standards. RESULTS: Data from 87/98 (88.7%) hospitals recruited 2177 patients, with 2116 confirmed as having ACS. Mean age was 61.4±11.8 years (range 20-95) and 58.7% (n=1242) were males. There were 813 (38.4%) patients with unstable angina, 695 (32.8%) with non-ST-elevation myocardial infarction (NSTEMI) and 608 (28.7%) with ST-elevation myocardial infarction (STEMI). Both STEMI (69.9%) and NSTEMI (61.4%) were more in males (P<0.001). Aspirin, clopidogrel and statins were given to over 90% in acute setting and on discharge. In STEMI, 407 (66.9%) were reperfused; 384 (63.2%) were given fibrinolytics and only 23 (3.8%) underwent primary percutaneous coronary intervention (PCI). Only 42.3 % had thrombolysis in <30 min and 62.5% had PCI in <90 min. On discharge, beta-blockers and ACE inhibitors/angiotensin II receptor blockers were given to only 50.7% and 69.2%, respectively and only 17.6% had coronary interventions planned. CONCLUSIONS: In patients with ACS, aspirin, clopidogrel and statin use met audit standards in acute setting and on discharge. Vast majority of patients with STEMI underwent fibrinolyisis than PCI, due to limited resources. Primary PCI, planned coronary interventions and timely thrombolysis need improvement in Sri Lanka.
引用
- Galappatthy P, Bataduwaarachchi VR, Ranasinghe P, et al. Management, characteristics and outcomes of patients with acute coronary syndrome in Sri Lanka. Heart. 2018. PMID: 29453329. doi:10.1136/heartjnl-2017-312404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。